Get the Stockscreener App
19.94
3.06%
-0.63
After Hours:
19.94
Ceribell Inc stock is traded at $19.94, with a volume of 196.72K.
It is down -3.06% in the last 24 hours and down -14.90% over the past month.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
See More
Previous Close:
$20.57
Open:
$20.69
24h Volume:
196.72K
Relative Volume:
0.45
Market Cap:
$739.69M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.10%
1M Performance:
-14.90%
6M Performance:
+70.43%
1Y Performance:
-10.66%
1-Day Range:
$19.80
$20.71
1-Week Range:
$18.78
$21.95
52-Week Range:
$10.01
$26.04
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
19.94 | 763.06M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jun-24-25 | Initiated | BTIG Research | Buy |
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
Market Overview: How sensitive is CeriBell Inc to inflation2025 Price Targets & Weekly Return Optimization Alerts - baoquankhu1.vn
FMR LLC Reduces Stake in CeriBell Inc: A Strategic Portfolio Adj - GuruFocus
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - The Manila Times
Ceribell Inc introduces new neonatal EEG at NEO Pediatrix event - Traders Union
Ceribell, Inc. shows power of POCEEG in seizure detection - Traders Union
Ceribell CEO Chao Xingjuan sells $786k in shares - Investing.com
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 5,556 Shares - MarketBeat
New medical partner - Northwest Indiana Business Magazine
What are the future prospects of CeriBell IncPortfolio Update Summary & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What is CeriBell Incs 5 year growth outlook2025 Dividend Review & Trade Opportunity Analysis Reports - baoquankhu1.vn
What is CeriBell Inc. s revenue forecastJuly 2025 Breakouts & Weekly Return Optimization Alerts - mfd.ru
Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook - TipRanks
BTIG Reiterates Buy Rating for CeriBell (CBLL) with $30 Price Ta - GuruFocus
Forecasting The Future: 5 Analyst Projections For CeriBell - Benzinga
Income Plays: Is CeriBell Inc a top pick in the sectorWeekly Loss Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Fed Meeting: What are the risks of holding CeriBell Inc2025 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn
What’s the profit margin of CeriBell Inc.Analyst Upgrade & Safe Entry Trade Reports - mfd.ru
CeriBell, Inc. $CBLL Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Ceribell director resigns to pursue other professional ventures - MSN
CeriBell, Inc. (CBLL) Stock Analysis: A 24% Potential Upside Beckons in the Dynamic Medical Device Sector - DirectorsTalk Interviews
Targets Report: Is Bolt Projects Holdings Inc stock a buy or sellPortfolio Return Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Ceribell director Parvizi sells $573k in shares By Investing.com - Investing.com South Africa
Josef Parvizi Sells 25,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell director Parvizi sells $573k in shares - Investing.com
CeriBell a new buy at BTIG on growth in EEG monitoring system - MSN
FDA clearances: Siemens Healthineers, Medtronic, CeriBell - Modern Healthcare
Risk Hedge: Does CeriBell Inc stock reflect fundamentalsJuly 2025 Levels & Daily Chart Pattern Signal Reports - baoquankhu1.vn
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion - Yahoo Finance
Growth Value: Does CeriBell Inc have consistent dividend growthAnalyst Downgrade & Real-Time Market Trend Scan - baoquankhu1.vn
Protara, Ceribell rise on FDA breakthrough designations - MSN
CBLL: FDA-cleared AI neuromonitoring expands to pediatrics and delirium, driving growth and efficiency - TradingView
CBLL: 2026 growth will accelerate with new FDA clearances, VA expansion, and pediatric launches - TradingView — Track All Markets
Ceribell sues Natus Medical for patent infringement - MSN
CeriBell, Inc. (NASDAQ:CBLL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Ceribell shares advance after FDA grants breakthrough device status - MSN
CeriBell, Inc.'s (NASDAQ:CBLL) Shares May Have Run Too Fast Too Soon - simplywall.st
Is CeriBell Inc. stock a buy on dips2025 Top Decliners & Long-Term Safe Return Strategies - Улправда
Is CeriBell Inc. stock attractive for retirement portfoliosOptions Play & AI Driven Price Predictions - ulpravda.ru
Will CeriBell Inc. stock rally after Fed decisions2025 Key Highlights & Reliable Intraday Trade Plans - ulpravda.ru
Aug Technicals: Why CeriBell Inc. stock could outperform in 2025Portfolio Risk Summary & High Return Trade Opportunity Guides - ulpravda.ru
FDA clearances and approvals: J&J, Abbott, Edwards Lifesciences - Modern Healthcare News
Ceribell’s Foehr sells $125k in shares after option exercise By Investing.com - Investing.com Nigeria
Xingjuan Chao Sells 79,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell CEO Chao Xingjuan sells $1.68 million in shares By Investing.com - Investing.com South Africa
Ceribell CEO Chao Xingjuan sells $1.68 million in shares - Investing.com
Pittsburgh Post-GazetteCeriBell, Inc.Common Stock (Nasdaq:CBLL) Detailed Stock Data - FinancialContent
Ceribell’s Foehr sells $125k in shares after option exercise - Investing.com
Will CeriBell Inc. stock benefit from infrastructure spendingFootwear buying guidance for recovery days and low impact training focuses on balanced cushioning and support, making it a solid option for daily use. - ulpravda.ru
Ceribell Gets FDA Breakthrough Device Status - Medical Device and Diagnostic industry
Ceribell’s AI Stroke Detection Tool Gains FDA Breakthrough Status - Zenopa
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection - Yahoo Finance
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):